Functional analyses using both tumor-intrinsic and CRISPR-Cas9-engineered CMTR2-mutant cells showed that CMTR2 deficiency induces global alterations in RNA splicing and increases vulnerability of the splicing machinery. The gene discussed is CMTR2; the disease is neoplasm.